PRESS RELEASE
Sep 16, 2024
VeganMed and Sater Pharmacy Team Up to Combat Alpha-gal Syndrome in Missouri
VeganMed is excited to announce its new partnership with Sater Pharmacy in Cassville, MO, to enhance support for Alpha-gal Syndrome patients. This collaboration aims to address the growing need for specialized, animal-free medication options in a state with one of the highest prevalence rates of the condition.
Sep 13, 2024
VeganMed’s Director of Medical Affairs and Operations Shares Insights on Hidden Animal Ingredients in Medicine with Vegconomist
Dr. Jasmine Uchi discusses the critical need for transparency around hidden animal ingredients in medications, advocating for consumer safety and informed choices.
Sep 11, 2024
VeganMed Partners with Love.Life Telehealth to Enhance Care for Alpha-gal Syndrome
VeganMed is thrilled to announce a new collaboration with Love.Life Telehealth. This partnership marks a significant step forward in addressing a critical issue identified through recent analysis: a widespread gap in knowledge among U.S. healthcare providers regarding Alpha-gal Syndrome (AGS).
Sep 3, 2024
Physician Awareness Key in Differentiating Chronic Spontaneous Urticaria and Alpha-gal Syndrome: New Insights from Leading Experts
An educational initiative aims to enhance physician awareness of the critical differences between Chronic Spontaneous Urticaria (CSU) and Alpha-gal Syndrome (AGS), two conditions with overlapping symptoms but distinct diagnostic and treatment approaches.
Aug 6, 2024
Groundbreaking TEDx Talk on Animal-Free Medications
VeganMed, Inc. is proud to share the highly anticipated TEDx Talk by Dr. Jasmine Uchi, focusing on the critical importance of animal-free medications for individuals with Alpha-gal Syndrome, vegans, vegetarians, and people with specific religious beliefs.
May 2, 2024
VeganMed CEO to Speak at First-Ever Congressional Briefing on Alpha-gal Syndrome
The U.S. Capitol will host its first-ever Congressional briefing dedicated to alpha-gal syndrome, a condition caused by tick bites that results in severe allergic reactions to mammalian meat, featuring a panel of esteemed experts and advocates.
Apr 8, 2024
New Study Unveils Medication Challenges for Alpha-gal Syndrome Patients at ACC 2024
A poster presentation at the American College of Cardiology (ACC) 73rd Annual Scientific Session & Expo highlights the challenges faced by individuals with Alpha-gal syndrome (AGS), revealing insights from social media discussions among AGS patients.
Jun 27, 2023
Study Reveals Alarming Medication Challenges Faced by Alpha-Gal Syndrome Patients
A survey presented at the DIA's Global Annual Meeting in Boston (June 2023) highlights the severe challenges faced by Alpha-Gal Syndrome (AGS) patients due to alpha-gal sugar molecules found in mammalian products.
Jun 22, 2023
Pharmaceutical Industry Faces Challenges in Providing Accurate Information on Animal-Derived Ingredients
Amidst a growing consumer demand for transparency in medication ingredients, a new pilot project reveals critical gaps in the pharmaceutical industry's ability to provide accurate information on animal-derived ingredients.